BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2455595)

  • 1. Biochemical characterization of tyrosine kinase and phosphotyrosine phosphatase activities of HL-60 leukemia cells.
    Frank DA; Sartorelli AC
    Cancer Res; 1988 Aug; 48(15):4299-306. PubMed ID: 2455595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
    Frank DA; Sartorelli AC
    Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of protein phosphotyrosine content by changes in tyrosine kinase and protein phosphotyrosine phosphatase activities during induced granulocytic and monocytic differentiation of HL-60 leukemia cells.
    Frank DA; Sartorelli AC
    Biochem Biophys Res Commun; 1986 Oct; 140(1):440-7. PubMed ID: 2430565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphotyrosine phosphatase activity in human placenta.
    Sako F; Taniguchi N; Makita A
    Jpn J Exp Med; 1985 Feb; 55(1):21-7. PubMed ID: 2993712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic epithelial cells in culture: phosphorylation of protein tyrosyl residues and tyrosine protein kinase activity.
    Bourassa C; Nguyen LT; Durocher Y; Roberts KD; Chevalier S
    J Cell Biochem; 1991 Aug; 46(4):291-301. PubMed ID: 1721913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary characterization of phosphotyrosine phosphatase activities in human peripheral blood lymphocytes: identification of CD45 as a phosphotyrosine phosphatase.
    George RJ; Parker CW
    J Cell Biochem; 1990 Feb; 42(2):71-81. PubMed ID: 2155244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of two-dimensional gel analysis to identification and characterization of tyrosine phosphorylated substrates for growth factor receptors.
    Hansen K; Møller JV
    Electrophoresis; 1993; 14(1-2):112-26. PubMed ID: 7681772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Liver phosphotyrosine protein phosphatase and tyrosine protein kinase in chemical hepatocarcinogenesis].
    Tsuiki S; Suzuki Y; Tamura S; Kikuchi K
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2010-7. PubMed ID: 3038031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the epidermal growth factor receptor by phosphorylation.
    Bertics PJ; Weber W; Cochet C; Gill GN
    J Cell Biochem; 1985; 29(3):195-208. PubMed ID: 3001110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Src kinase regulation by phosphorylation and dephosphorylation.
    Roskoski R
    Biochem Biophys Res Commun; 2005 May; 331(1):1-14. PubMed ID: 15845350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid differentiation associated tyrosine protein kinase activity in WEHI-3B murine monomyelocytic leukemia cells.
    DiGiovanna MP; Sartorelli AC
    Leukemia; 1991 Oct; 5(10):869-78. PubMed ID: 1720491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate.
    Landry F; Chapdelaine A; Bégin LR; Chevalier S
    J Urol; 1996 Jan; 155(1):386-90. PubMed ID: 7490893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases.
    Torres M; Hall FL; O'Neill K
    J Immunol; 1993 Feb; 150(4):1563-77. PubMed ID: 7679431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinase and CD45 tyrosine phosphatase activity mediate p21ras activation in B cells stimulated through the antigen receptor.
    Kawauchi K; Lazarus AH; Rapoport MJ; Harwood A; Cambier JC; Delovitch TL
    J Immunol; 1994 Apr; 152(7):3306-16. PubMed ID: 7511643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of a protein-phosphotyrosine phosphatase from rat spleen which dephosphorylates and inactivates a tyrosine-specific protein kinase.
    Swarup G; Subrahmanyam G
    J Biol Chem; 1989 May; 264(14):7801-8. PubMed ID: 2542246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ; Ince C; Rosenblum MG; Gallick GE
    J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Puromycin is a potent and specific inhibitor of tyrosine kinase activity in HL-60 cells.
    Davidoff AN; Mendelow BV
    Anticancer Res; 1992; 12(5):1761-6. PubMed ID: 1280034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quantity of protein-bound [32P]phosphotyrosine in hepatocytes and fibroblasts. The effects of tyrosine protein kinase activating agents.
    Ekman P; Ek B; Engström L
    J Biochem; 1987 Apr; 101(4):863-70. PubMed ID: 2440855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine kinase and phosphotyrosine phosphatase activity in human promyelocytic leukemia cells and human polymorphonuclear leukocytes.
    Kraft AS; Berkow RL
    Blood; 1987 Aug; 70(2):356-62. PubMed ID: 3038210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphotyrosine phosphatase: a novel phosphatase specific for phosphotyrosine, 2'-AMP and p-nitrophenylphosphate in rat brain.
    Motoyama N; Takimoto K; Okada M; Nakagawa H
    J Biochem; 1987 Apr; 101(4):939-47. PubMed ID: 2440857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.